Stroke and dementia in the Women's Health Initiative clinical trial of estrogen plus progestin

被引：0
|
作者：
Wassertheil-Smoller, S [1 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF HYPERTENSION | 2004年 / 22卷
关键词：
D O I：
10.1097/00004872-200406002-00512
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
下载
收藏
页码：S149 / S150
页数：2
相关论文
共 50 条
  • [31] Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials
    Crandall, Carolyn J.
    Aragaki, Aaron K.
    Cauley, Jane A.
    McTiernan, Anne
    Manson, JoAnn E.
    Anderson, Garnet
    Chlebowski, Rowan T.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (01) : 275 - 285
  • [32] Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
    Carolyn J. Crandall
    Aaron K. Aragaki
    Jane A. Cauley
    Anne McTiernan
    JoAnn E. Manson
    Garnet Anderson
    Rowan T. Chlebowski
    Breast Cancer Research and Treatment, 2012, 132 : 275 - 285
  • [33] Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial - Comments
    Tucker, G
    CLIMACTERIC, 2003, 6 (04) : 310 - 312
  • [34] Estrogen plus progestin and coronary heart disease risk: Final results from the women's health initiative randomized trial
    Hsia, J
    Manson, JE
    Johnson, KC
    Assaf, AR
    Lasser, NL
    Trevisan, M
    Black, HR
    Heckbert, SR
    Detrano, R
    Wong, ND
    Crouse, JR
    Stein, E
    Cushman, M
    CIRCULATION, 2003, 108 (17) : 787 - 787
  • [35] Breast cancer after stopping estrogen plus progestin in postmenopausal women in the women's health initiative.
    Chlebowski, R. T.
    Kuller, L.
    Anderson, G.
    Mason, J. A.
    Schenken, R.
    Rajkovic, A.
    Stefanick, M.
    Sarto, G.
    Ravdin, P.
    Prentice, R.
    CANCER RESEARCH, 2009, 69 (02) : 78S - 79S
  • [36] Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial - Reply
    Shapiro, S
    CLIMACTERIC, 2003, 6 (04) : 313 - 313
  • [37] Continuous combined oestrogen plus progestin and endometrial cancer in postmenopausal women in the Women's Health Initiative randomized clinical trial
    Chlebowski, R.
    Anderson, G. L.
    Sarto, G.
    Haque, R.
    Runowicz, C.
    Aragaki, A.
    Thomson, C. A.
    Howard, B. V.
    Reed, S.
    Manson, J. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S7 - S7
  • [38] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
    Rossouw, JE
    Anderson, GL
    Prentice, RL
    LaCroix, AZ
    Kooperberg, C
    Stefanick, ML
    Jackson, RD
    Beresford, SAA
    Howard, BV
    Johnson, KC
    Kotchen, JM
    Ockene, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 321 - 333
  • [39] Effect of estrogen plus progestin on global cognitive function in postmenopausal women - The Women's Health Initiative Memory Study: A randomized controlled trial
    Rapp, SR
    Espeland, MA
    Shumaker, SA
    Henderson, VW
    Brunner, RL
    Manson, JE
    Gass, MLS
    Stefanick, ML
    Lane, DS
    Hays, J
    Johnson, KC
    Coker, LH
    Dailey, M
    Bowen, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (20): : 2663 - 2672
  • [40] Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings: authors' response
    Shapiro, Samuel
    Farmer, Richard D. T.
    Stevenson, John C.
    Burger, Henry G.
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2013, 39 (03): : 228 - 229
12345